Moderna just got a signal investors can’t ignore
Moderna (MRNA) has been struggling to shake one label for years: Covid winner. That label helped to make the company famous, but it also became a problem for the stock when pandemic demand dropped and investors questioned whether Moderna could develop a stable business beyond one historic product ...
The Source
THE STREET
Business
Europe fires another salvo at U.S. tech companies
THE STREET·41m ago·3 min read
Business
Ford faces another setback involving its most important vehicle
THE STREET·31m ago·3 min read
Business
AMC stock traders ignoring warning signs send shares surging
THE STREET·1h ago·3 min read
Business
How much will people spend on Dad for Father’s Day?
THE STREET·2h ago·3 min read
Related
On this beat
Business
Europe should speak to Putin, says Austrian chancellor
FT·3h ago·3 min read
Business
AI pioneer Yann LeCun calls Elon Musk’s xAI a ‘faliure’
BI·1h ago·3 min read
Business
Iran to get access to $6bn of frozen funds to buy US goods
FT·1h ago·3 min read
Business
A company built a ‘Michelin-star workspace’ designed to reduce stress. It has indoor plants, massages, and a custom scent.
BI·1h ago·3 min read